Optivia Receives $1.9M SBIR Grant for Membrane Transporter Research

The grant from NIGMS will be used to develop assays and databases to identify the most clinically significant drug-to-drug interactions involving membrane transporters.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories